The 26 analysts offering 12-month price forecasts for Biogen Inc have a median target of 325.00, with a high estimate of 370.00 and a low estimate of 247.00. The median estimate represents a +11.52% increase from the last price of 291.44.
The current consensus among 33 polled investment analysts is to Buy stock in Biogen Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $3.48
Reporting Date Feb 02
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.